Bionano Genomics Q2 Revenue USD 8.2 Million
BNGO•Other Q2 Metrics
- Q2 gross margin: 53%
- Q2 adjusted operating expenses: USD 8.7 million
Q2 Revenue and Operating Expenses
Aug. 10 (Reuters) - Bionano Genomics Q2 revenue was USD 8.2 million. Q2 operating expenses were USD 11.5 million.




